service

PGT involves screening embryos for genetic abnormalities before transfer. PGT can help identify embryos with a higher likelihood of implantation and reduce the risk of certain genetic conditions.

Analyzes fetal tissue after miscarriage or abortion. It identifies chromosomal abnormalities, genetic causes, or structural issues underlying pregnancy loss. This information helps couples understand potential factors, enabling informed decisions and guiding future reproductive choices and interventions.  

BRCA1/BRCA2 gene sequencing identifies mutations linked to breast and ovarian cancers. Testing assesses genetic risk, aiding personalized screening and prevention strategies. Positive results inform decisions about surveillance, prophylactic surgery, and targeted therapies, enhancing early detection and management of hereditary cancer risks.

Amniocentesis is a prenatal diagnostic test involving the removal of a small amount of amniotic fluid from the uterus. It helps detect genetic disorders, neural tube defects, and other fetal conditions. Guiding treatment decisions, it carries a slight risk of complications and is typically performed in the second trimester.

Non-Invasive Prenatal Testing (NIPT) analyzes fetal DNA from maternal blood to screen for chromosomal abnormalities like Down syndrome. Safe and accurate, NIPT provides early insight into the baby’s health without invasive procedures, aiding informed decisions and guiding further diagnostic steps if needed. We are the only center in Nepal which has in house NIPT test […]

Surgical restoration of the hymen, often requested for cultural or personal reasons.

Pap smear with liquid-based cytology is a cervical cancer screening method. It involves collecting cervical cells, suspending them in a liquid medium, and analyzing for abnormalities. This technique enhances sample quality, reduces false negatives, and improves early detection of cervical abnormalities, guiding timely interventions.